Basic earnings per share is calculated by dividing net earnings by the weighted average number of shares of common stock outstanding. Diluted earnings per share is calculated by adjusting weighted average common shares outstanding for the dilutive effect of the assumed issuance of shares under stock-based compensation plans, determined using the treasury-stock method, except where the inclusion of such shares would have an anti-dilutive impact.


	Three Months Ended				Six Months Ended
(in millions, except per share amounts)	June 27, 2025		June 28, 2024		June 27, 2025		June 28, 2024
Numerator:
Net earnings	$	91.9	$	70.1	$	179.8	$	206.9

Denominator:
Basic weighted average common shares outstanding	147.7		154.4		148.3		154.4
Effect of dilutive stock options and RSUs	0.5		1.1		0.5		1.1
Diluted weighted average common shares outstanding	148.2		155.5		148.8		155.5

Earnings per share:
Basic	$	0.62	$	0.45	$	1.21	$	1.34
Diluted	$	0.62	$	0.45	$	1.21	$	1.33

Anti-dilutive shares	1.3		0.3		1.2		0.7

On April 30, 2025, the Company’s Board of Directors approved a replenishment of the Company’s previously approved share repurchase program announced in May 2021 and replenished in May 2022, bringing the total amount authorized for future share repurchases to $500 million. Under the share repurchase program, the Company may purchase shares of common stock from time to time in open market transactions, privately negotiated transactions, accelerated share repurchase programs, or by combinations of such methods, any of which may use prearranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company’s stock price, corporate and regulatory requirements, restrictions under the Company’s debt obligations and other market and economic conditions. The share repurchase program may be suspended or discontinued at any time and has no expiration date.